Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 27: 701-703, 1981;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hendel, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hendel, J.

Clinical Chemistry, Vol 27, 701-703, Copyright © 1981 by American Association for Clinical Chemistry

Radioimmunoassay for pteroylglutamic acid

J Hendel

I describe a radioimmunoassay for specific determination of pteroylglutamate in plasma, erythrocytes, and urine. Antiserum was raised in rabbits immunized with a conjugate of pteroylglutamic acid and methylated bovine serum albumin. The lowest detection limit of the assay was 0.1 microgram/L; the coefficient of variation ranged from 4.01 to 14.63%. No significant interference was demonstrated from tetrahydrofolic acid, 5-methyl-tetrahydrofolic acid, or methotrexate. Under normal sampling and storing conditions dihydrofolic acid was oxidized to pteroylglutamic acid and estimated as such in the assay. The clinical applicability of the assay is demonstrated by measurements of pteroylglutamate absorption rates after oral doses of pteroylglutamic acid or pteroyltriglutamic acid and by the estimation of the accumulation of pteroylglutamate and dihydrofolate in plasma during therapy with methotrexate.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Association for Clinical Chemistry.